Cited by 3Pharmaceutical Economics and PolicyPublic Procurement and PolicyAuction Theory and Applications

The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.

The Impact of Pharmaceutical Electronic Bidding Procurement on Prices of Medicines: A Systematic Review

Open access
Pentrakan, Amarawan, Han Lin, Kuan, Sriphon, Thitima, Yi Wang, Jiun, Keung Wong, Wing·2022·Indian Journal of Pharmaceutical Sciences

Abstract

An electronic bidding system promises to save resources in procurement procedures for many industries. While the results of previous studies in several countries sounded promising, it is concerning that more evidence would be needed to support changes in practice for the pharmaceutical sector. The objective of this study was to determine the prevalence of price saving in bidding-based electronic procurement setting and to clarify the main factors contributing to drug price changes. A comprehensive literature search was retrieved from five databases (Scopus, PubMed, ProQuest, Web of Science, Medline) to identify articles that studied the prices of medicines as a case study before and after the implementation of the electronic bidding system. Articles that were published in English from January 2012 to December 2021 were eligible for inclusion. The result showed that a total of 3214 records articles were identified in the electronic databases after the exclusion of duplicate articles. After the initial review, we found 13 studies that fulfilled our inclusion criteria. The review presented the important information suggesting that the use of the electronic bidding system likely results in a reduction in procurement prices of medicines. The prevalence of price saving for pharmaceutical procurement ranged from 7.24 % to 40 %. Additionally, the following factors were indirectly associated with drug price changes; bid volume, procurement location, contract characteristics, level of competitiveness and procurement organization. Further research may need to examine the functioning of e-bidding policies to address problems like supply disruptions to preserve the integrity of bidding-based pharmaceutical systems.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.36468/pharmaceutical-sciences.spl.575

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Research works printed but not linked: 5

  1. Jaśkowski P, Czarnigowska A. Contractor's bid pricing strategy: A model with correlation among competitors' prices. Open Eng 2019;9(1):159-66. · DOI
  2. Chuang CH, Tseng PC, Lin CY, Lin KH, Chen YY. Burnout in the intensive care unit professionals: A systematic review. Medicine 2016;95(50):e5629.
  3. Roy V. A way to low cost, quality medicines: Implementation of an essential medicines policy in public health facilities in Delhi (India). Int J Res Pharm Sci 2013;4(3):397-410.
  4. San Santoso D, Bourpanus N. Moving to e-bidding: Examining the changes in the bidding process and the bid mark-up decisions of Thai contractors. J Financial Manag Proper Constr 2018;24(1):2-18. · DOI
  5. Rizzo JA. Advertising and competition in the ethical pharmaceutical industry: The case of antihypertensive drugs. J Law Econ 1999;42(1):89-116. · DOI

Cited by

Sorted by citations

Metadata

Authors
Pentrakan, A., Han Lin, K., Sriphon, T., Yi Wang, J., & Keung Wong, W.
Affiliations
  • Prince of Songkla University (TH)
  • Asia University (TW)
Corresponding author
Pentrakan, Amarawan
Venue
Indian Journal of Pharmaceutical Sciences
Published
2022
Volume
84
Issue
S5
ISSN
0250-474X (ISSN-L)
OpenAlex
W4318256390
Cited by
3
References
45
Citations by year
2025: 1 · 2024: 1 · 2023: 1
FWCI
0.14
Type
journal article
Language
en
Open access
Locations
Indian Journal of Pharmaceutical Sciences (publishedVersion)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
  • Social Sciences › Business, Management and Accounting › Strategy and Management › Public Procurement and Policy
  • Social Sciences › Decision Sciences › Management Science and Operations Research › Auction Theory and Applications
Keywords
electronic bidding, drug procurement, drug prices, discounts, contract characteristics, supply disruption

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review